Skip to main content

Advertisement

SpringerLink
Log in

Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer’s disease in vivo?

  • Controversies-Against
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

An Erratum to this article was published on 04 March 2005

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351–7.

    Article  CAS  PubMed  Google Scholar 

  2. Thal DR, Rub U, Orantoes M, Braak H. Phases of A-beta deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791–800.

    PubMed  Google Scholar 

  3. Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992;256:184–5.

    CAS  PubMed  Google Scholar 

  4. Schönheit B, Zarski R, Ohm T. Spatial and temporal relationship between plaques and tanges in Alzheimer-pathology. Neurobiol Aging 2004;25:697–711.

    PubMed  Google Scholar 

  5. Nordberg A, Lundqvist H, Hartvig P, Lilja A, Långström B. Kinetic analysis of regional (S)(−)11C-nicotine binding in normal and Alzheimer brains—in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 1995;1:21–7.

    Google Scholar 

  6. Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Azheimer’s disease. Neurology 1999;52:691–9.

    CAS  PubMed  Google Scholar 

  7. Selkoe DJ. Alzheimer’s disease is a synaptic failure. Science 2002;298:789–91.

    Article  CAS  PubMed  Google Scholar 

  8. DeKosky ST, Ikonomovic MD, Styren SD, Becket L, Wisniewski S, Bennett DA, et al. Upregulation of choline acetyltransferase activity in the hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145.

    Article  CAS  PubMed  Google Scholar 

  9. Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. Correlation between levels of amyloid beta-peptide in the brain and cognitive decline. J Am Med Assoc 2000;283:1571–7.

    Article  Google Scholar 

  10. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A 2004;101:284–9.

    Google Scholar 

  11. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, et al. Cerebrospinal fluid tau and β-amyloid. Arch Neurol 2003;60:1696–702.

    Article  PubMed  Google Scholar 

  12. Friedland RP, Majocha RE, Reno JM, Lyle LR, Marotta CA. Development of an anti-A-beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer’s disease. Mol Neurobiol 1994;9:107–13.

    CAS  PubMed  Google Scholar 

  13. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, et al. Molecular targeting Azheimer’s amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 2002;11:315–29.

    Article  CAS  PubMed  Google Scholar 

  14. Klunk WE, Debnath ML, Pettegrew JW. Development of small molecule probes for the betaamyloid protein of Alzheimer’s disease. Neurobiol Aging 1994;15:691–8.

    Article  CAS  PubMed  Google Scholar 

  15. Klunk WE, Engler H, Nordberg A, Bacskai BJ, Wang Y, Price J, et al. Imaging the pathology of Alzheimer’s diseases: amyloid-imaging with positron emission tomography. Neuroimaging Clin N Am 2003;13:781–9.

    PubMed  Google Scholar 

  16. Nordberg A. PET imaging of amyloid in Alzheimer’s disease. Lancet Neurol 2004;3:519–27.

    Article  PubMed  Google Scholar 

  17. Shoghi-Jadid K, Small D, Agdeppa ED, Kepe V, Ercoli LM, Read S, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brain of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002;10:24–35.

    Article  PubMed  Google Scholar 

  18. Klunk EW, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 2004;55:306–19.

    Google Scholar 

  19. Agdeppa ED, Kepe V, Liu J, Small GW, Huang SC, Petric A, et al. Dialkylamino-6-acylmalonnonitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tool in Alzheimer’s disease. Mol Imaging Biol 2003;5:404–17.

    Article  PubMed  Google Scholar 

  20. Bresjanac M, Smid LM, Vovko TD, Petric A, Barrio JR, Popovic M. Molecular-imaging probe-2-(1-[6-[(fluoroethyl)(methyl)amino-2-naphthyl]ethylidene)malonitrile labels prion plaques in vitro. J Neurosci 2003;23:8029–33.

    Google Scholar 

  21. Petersen RC, Doody R, Kurz A, Mohs RC, Rabin PV, Ritchie K, et al. Current concept in mild cognitive impairment. Arch Neurol 2001;58:1985–92.

    Article  CAS  PubMed  Google Scholar 

  22. Wolf H, Jelic V, Gertz HJ, Nordberg A, Juhlin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl 2003;179:52–76.

    Article  PubMed  Google Scholar 

  23. Klunk WE, Price JC, Lopresti BJ, Debnath ML, Holt DP, Meltzer C, et al. Human amyloid-imaging studies in controls, mild cognitive impairment and Alzheimer’s disease using Pittsburgh Compound-B. Ninth international conference on Alzheimer’s disease and related disorders, Philadelphia, Pennsylvania. USA, 17–22 July 2004, abstr O-3-03-05.

  24. Nordberg A, Engler H, Blomqvist G, Almkvist O, Ausén B, Wall A, Långström B. Imaging of amyloid in vivo in MCI and AD patients. Ninth international conference on Alzheimer’s disease and related disorders, Philadelphia, Pennsylvania. USA, 17–22 July 2004, abstr O-3-03-08.

  25. Cummings JL. Alzheimer’s disease. N Engl J Med 2004;351:56–67.

    Google Scholar 

  26. Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003;61:46–54.

    CAS  PubMed  Google Scholar 

  27. Nicoll JAR, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 2003;9:448–52.

    Article  CAS  PubMed  Google Scholar 

  28. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In vivo measurement of activated microglia in dementia. Lancet 2001;11:461–7.

    Article  Google Scholar 

  29. Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergström M, et al. Multitracer study with positron emission tomography in Creutzfeld-Jakob disease. Eur J Nucl Med Mol Imaging 2003;30:85–95.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurotec Department, Karolinska Institutet, Karolinska University Hospital Huddinge B84, 141 86, Stockholm, Sweden

    Agneta Nordberg

Authors
  1. Agneta Nordberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Agneta Nordberg.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00259-004-1758-8

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nordberg, A. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer’s disease in vivo?. Eur J Nucl Med Mol Imaging 31, 1540–1543 (2004). https://doi.org/10.1007/s00259-004-1677-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-004-1677-8

Keywords

Search

Navigation